Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)

Abroad (travel likely)RecruitingPHASE1

Conditions

Cryopyrin-associated Periodic Syndromes (CAPS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Gordon Sussman Clinical Research Inc., North York, Ontario, Canada

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load

Cryopyrin-Associated Periodic Syndromes · Amyloidosis

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Ilaris NIS in Korea

Hereditary Periodic Fever Syndromes · Cryopyrin-associated Periodic Syndromes (CAPS) · Colchicine Resistance Familial Mediterranean Fever (crFMF)

Abroad (travel likely)Recruiting

Seoul, South Korea